Skip to main content

Find Clinical Trials

Home
Conditions
Anemia, Refractory

Clinical trial condition

Anemia, Refractory

Explore clinical trials studying Anemia, Refractory. Study availability and eligibility vary by location and protocol.

193 public trials 36 recruiting studies

Refine in advanced search Browse all conditions

Anemia, Refractory trial results

Completed

Umbilical Cord Blood Stem Cell Transplantation in Adults With Advanced Blood Disorders or Cancer

NCT00312429

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +22 more
Locations: Duke University Durham, North Carolina, United States

View Trial Details

Completed

Umbilical Cord Blood Transplantation in Treating Patients With High-Risk Hematologic Cancer

NCT00003335

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +56 more
Locations: Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Completed

T-Cell-Depleted Allogeneic Stem Cell Transplantation After Immunoablative Induction Chemotherapy and Reduced-Intensity Transplantation Conditioning in Treating Patients With Hematologic Malignancies

NCT00080925

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +65 more
Locations: Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office Bethesda, Maryland, United States

View Trial Details

Completed

A Phase 1 Dose Escalating Trial of Bortezomib in Combination With Lenalidomide in Patients With Myelodysplasia

NCT00580242

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +5 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

Dana Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Completed

Safety Study of MultiStem® in Patients With Acute Leukemia, Chronic Myeloid Leukemia, or Myelodysplasia

NCT00677859

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +12 more
Locations: Mayo Clinic Hospital Phoenix, Arizona, United States

University Hospitals Case Medical Center Cleveland, Ohio, United States

Oregon State University Medical Center Portland, Oregon, United States

University of Pennsylvania Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Non-Ablative Allo HSCT For Hematologic Malignancies or SAA

NCT00006379

Conditions: Amyloidosis, Anemia, Anemia, Refractory, +100 more
Locations: Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Completed

FR901228 in Treating Patients With Myelodysplastic Syndrome, Acute Myeloid Leukemia, or Non-Hodgkin's Lymphoma

NCT00042822

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +29 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

Study of Vaccination With Autologous Acute Myeloblastic Leukemia Cells in Patients With Advanced Myelodysplasia or Acute Myelogenous Leukemia

NCT00136422

Conditions: Acute Myelogenous Leukemia, Anemia, Anemia, Refractory, +11 more
Locations: Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Completed

Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer

NCT00003661

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +54 more
Locations: University of Florida Health Science Center Gainesville, Florida, United States

Division of Pediatric Surgery Jacksonville, Florida, United States

Nemours Children's Clinic Jacksonville, Florida, United States

H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States

View all 17 locations

View Trial Details

Completed

Cellular Adoptive Immunotherapy in Treating Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndromes That Relapsed After Donor Stem Cell Transplant

NCT00107354

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +17 more
Locations: Fred Hutchinson Cancer Research Center Seattle, Washington, United States

View Trial Details